Utkarsh Odisha Conclave 2025: Summa Real Media showcases upcoming pharmaceutical arm ‘SUM Lifesciences’

Tuhina Sahoo

 Bhubaneswar, Jan 31: At the Utkarsh Odisha Conclave 2025, Summa Real Media Private Limited (SRMPL) showcased its upcoming pharmaceutical arm ‘SUM Lifesciences’ which aims to manufacture medicinal products and make it affordable for everyone.

Join the Whatsapp Channel to Get News updates in english

 This marks a significant step for the company, which has been in business for over 12 years in various manufacturing sectors like paper products, publishing, education, healthcare and media. Now, they are turning their focus toward revolutionizing healthcare in Odisha and beyond.

Narottam Das, Senior Manager, Sum Lifesciences shared his enthusiasm about the future of SUM Lifesciences and said, “At SUM Lifesciences, we are focused on creating innovative solutions to make healthcare accessible for all. We’re proud to launch our new venture at the Utkarsh Odisha Conclave, where we can showcase our commitment to sustainability, cutting-edge technology, and improving lives through affordable healthcare.”

The company's Managing Director, Prof. (Dr.) Manojranjan Nayak, is no stranger to innovation. He’s also the founder of Siksha 'O' Anusandhan Deemed to be University, one of the most renowned educational institutions in the country. His leadership brings valuable expertise and vision to SUM Lifesciences.

SUM Lifesciences is driven by a bold vision to become a global leader in the pharmaceutical industry, recognized for its commitment to sustainability and ethical business practices. The mission goes beyond just producing medicines—they aim to exceed customer expectations while fostering continuous innovation and improvement.

As part of their sustainability efforts, SUM Lifesciences plans to integrate green technologies into their manufacturing processes and reduce waste. This not only supports the environment but also appeals to eco-conscious consumers seeking products that align with their values.

Recognizing the power of collaboration, SUM Lifesciences is working to build strategic partnerships with leading research institutions and technology providers. By leveraging the expertise of these partners, the company hopes to drive further innovation and enhance their product offerings, all while ensuring that these advancements are accessible and impactful.

One of SUM Lifesciences' core goals is to make essential healthcare products affordable for everyone. From antibiotics and vaccines to anti-inflammatory medications and IV fluids, their range of products will cater to the needs of a broad audience. The company is dedicated to ensuring that high-quality medicines are available at prices that are within reach of the masses.

SUM Lifesciences is also focused on implementing lean manufacturing techniques and automation to streamline operations. This will allow them to reduce costs while maintaining the highest standards of quality and compliance. Their commitment to innovation in manufacturing will help them stand out in an increasingly competitive market.

With plans to build state-of-the-art manufacturing facilities, SUM Lifesciences is committed to adhering to FDA regulations, ensuring that all products meet the highest safety and quality standards. The company is also taking steps to comply with international regulations, which will open the door to global trade and ensure that their products meet the needs of diverse markets.